Delivering a Bipolar I Disorder Diagnosis

Introduction to Bipolar I Disorder

The American Academy of Child and Adolescent Psychiatry states that bipolar I disorder is a serious, chronic condition requiring ongoing treatment, but it is highly treatable with modern medications and psychotherapy, and the diagnosis itself does not determine the patient's future quality of life or potential for recovery 1, 2

The American Academy of Child and Adolescent Psychiatry recommends that multiple FDA-approved medications exist specifically for bipolar disorder, including lithium, valproate, and several atypical antipsychotics, with response rates ranging from 38-62% for individual agents and higher rates with combination therapy 2
Lithium reduces suicide attempts 8.6-fold and completed suicides 9-fold—an effect independent of its mood-stabilizing properties, as stated by the Journal of the American Academy of Child and Adolescent Psychiatry 2
The Journal of Clinical Oncology suggests that recovery is possible, and with maintenance therapy continued for at least 12-24 months after stabilization, many patients achieve sustained remission 2
Treatment combines medication with psychoeducation and psychotherapy, which have strong evidence for improving outcomes, according to the Journal of Clinical Oncology and the American Academy of Child and Adolescent Psychiatry 1, 2

The Journal of the American Academy of Child and Adolescent Psychiatry states that bipolar disorder has biological underpinnings and is not a character flaw or personal failure 3
Medication adherence is critical, with over 90% of adolescents who were noncompliant with lithium relapsing, compared to 37.5% of those who were compliant, as reported by the American Academy of Child and Adolescent Psychiatry 2

The American Academy of Pediatrics suggests that it's completely understandable to feel overwhelmed, scared, or uncertain right now, and these are normal reactions to receiving a diagnosis like this 5
Bipolar disorder is episodic, and with treatment, the goal is to prevent or minimize future episodes, with many patients achieving long periods of stability, according to the American Academy of Child and Adolescent Psychiatry 2

The Journal of Clinical Oncology recommends starting with first-line medication, such as lithium, valproate, or an atypical antipsychotic, with clear explanation of expected timeline for response 2
Schedule close follow-up within 1-2 weeks to assess response, side effects, and provide ongoing support, as suggested by the American Academy of Child and Adolescent Psychiatry 2
Arrange psychoeducation sessions to help the patient and their family understand the illness, recognize early warning signs, and develop coping strategies, according to the Journal of Clinical Oncology and the American Academy of Child and Adolescent Psychiatry 1, 2

The Journal of Clinical Oncology suggests using simple, direct language without medical jargon, and providing information in small chunks, checking regularly for understanding 1
Allow the patient to express feelings, and communicate nonabandonment, as recommended by the American Academy of Pediatrics and the Journal of Clinical Oncology 1, 5

The Journal of Clinical Oncology recommends involving family members or trusted support persons in the discussion, with the patient's permission, and explaining that family-focused therapy helps with medication supervision, early warning sign identification, and reducing environmental stressors 1, 2

The Journal of Clinical Oncology states that the diagnosis is a tool for guiding treatment, not a prediction of the patient's future potential or worth, and reassessing the patient's understanding, goals, and emotional state at every follow-up visit, adjusting the treatment plan as needed 1